Cargando…
Antigenic Targets for the Immunotherapy of Acute Myeloid Leukaemia
One of the most promising approaches to preventing relapse is the stimulation of the body’s own immune system to kill residual cancer cells after conventional therapy has destroyed the bulk of the tumour. In acute myeloid leukaemia (AML), the high frequency with which patients achieve first remissio...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6406328/ https://www.ncbi.nlm.nih.gov/pubmed/30678059 http://dx.doi.org/10.3390/jcm8020134 |